Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Guggenheim Maintains Buy on Gentex, Raises Price Target to $40

Author: Benzinga Newsdesk | March 19, 2024 07:21am
Guggenheim analyst Ronald Jewsikow maintains Gentex (NASDAQ:GNTX) with a Buy and raises the price target from $38 to $40.

Posted In: GNTX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist